Bank Of Montreal Acadia Pharmaceuticals Inc Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $1.41 Million - $1.77 Million	96,225 New	96,225 $1.56 Million
Q3 2022 Nov 10, 2022	SELL	$14.11 - $18.27 $2,723 - $3,526	-193 Reduced 0.07%	282,181 $5.04 Million
Q2 2022 Aug 11, 2022	BUY	$13.01 - $27.22 $3.67 Million - $7.69 Million	282,374 New	282,374 $5.03 Million
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $1.23 Million - $1.99 Million	-73,552 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $132,473 - $207,944	-8,395 Reduced 10.24%	73,552 $1.28 Million
Q2 2021 Aug 12, 2021	BUY	$19.4 - $27.42 $1.59 Million - $2.25 Million	81,947 New	81,947 $2.07 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.